D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients
Open Access
- 8 April 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 22 (7), 415-425
- https://doi.org/10.1093/ijnp/pyz017
Abstract
Positron emission tomography studies examining differences in D1-dopamine receptor binding between control subjects and patients with schizophrenia have been inconsistent, reporting higher, lower, and no difference in the frontal cortex. Exposure to antipsychotic medication has been suggested to be a likely source of this heterogeneity, and thus there is a need for studies of patients at early stages of the disorder who have not been exposed to such drugs. Here, we compared 17 healthy control subjects and 18 first-episode neuroleptic naive patients with schizophrenia or schizophreniform psychosis using positron emission tomography and the D1-dopamine receptor radioligand [11C]SCH23390. We observed a statistically significant difference in the dorsolateral prefrontal cortex. Contrary to our expectations, patients had less D1-dopamine receptor availability with a moderate effect size. In a Bayesian analysis, we show that the data are over 50 times more likely to have occurred under the decrease as opposed to the increase hypothesis. This effect was not global, as our analysis showed that the null hypothesis was preferred over either hypothesis in the striatum. This investigation represents the largest single sample of neuroleptic-naive patients examined for D1-dopamine receptor availability using PET and suggests a reduction of prefrontal D1-dopamine receptor density in the pathophysiology of schizophrenia. However, further work will be required to reach a consensus.Keywords
Funding Information
- Swedish Science Council (2015–02398)
This publication has 84 references indexed in Scilit:
- Dopamine D1 receptors and age differences in brain activation during working memoryNeurobiology of Aging, 2011
- Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophreniaLife Sciences, 2010
- Meta-analysis of 41 Functional Neuroimaging Studies of Executive Function in SchizophreniaArchives of General Psychiatry, 2009
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common PathwaySchizophrenia Bulletin, 2009
- Psychiatric Symptoms and Quality of Life in Schizophrenia: A Meta-AnalysisSchizophrenia Bulletin, 2007
- Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomographyLife Sciences, 2000
- The Human Dopamine D5 Receptor Gene: Cloning and Characterization of the 5'-Flanking and Promoter RegionBiochemistry, 1995
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987
- Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomographyInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986
- Head Fixation Device for Reproducible Position Alignment in Transmission CT and Positron Emission TomographyJournal of Computer Assisted Tomography, 1981